New genomic test aims to personalize cancer care for thousands
NCT ID NCT07555639
First seen Apr 30, 2026 · Last updated Apr 30, 2026
Summary
This study is testing a new genetic test called the Gersom panel in 4,000 people with breast, ovarian, or colorectal cancer. The goal is to see if the test can accurately find inherited genetic risks and tumor changes that might guide treatment choices. Participants provide blood or tumor samples, and researchers compare the test results to standard methods. This is a research study, not a treatment, and aims to improve future cancer care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli, IRCCS
Roma, Roma, 00136, Italy
Conditions
Explore the condition pages connected to this study.